As of Feb 12
| +0.63 / +12.88%|
The 3 analysts offering 12-month price forecasts for Sorrento Therapeutics Inc have a median target of 22.00, with a high estimate of 45.00 and a low estimate of 15.00. The median estimate represents a +298.55% increase from the last price of 5.52.
The current consensus among 3 polled investment analysts is to Buy stock in Sorrento Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.